Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis

Fig. 1

Graphic summary of studies on the combination therapy of SRS and ICI for brain metastases by tumor types, intervention/control arms, and intervals between SRS and ICI defined as “concurrent”. A: Concurrent SRS + ICI vs. SRS; B: Concurrent SRS + ICI vs. non-Concurrent SRS + ICI; C: Concurrent SRS + ICI vs. SRS after ICI; D: Concurrent SRS + ICI vs. SRS before ICI; E: Concurrent SRS + /before ICI vs. SRS after ICI; F: Non-concurrent SRS + ICI vs. SRS; G: Concurrent SRS + ICI vs. Concurrent WBRT + ICI

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us